Søgeord (covid-19) valgt.
581 emner vises.
1
Covid-19-smitte gav ikke flere alvorlige infektionssygdomme
Statens Serum Institut, 25.09.2023
Tilføjet 25.09.2023
Der var ikke flere voksne, der blev indlagt med alvorlige infektionssygdomme, efter de havde været smittet med covid-19. Det viser en ny stor undersøgelse fra Statens Serum Institut, hvor 78.000 indlæggelser er blevet analyseret.
Læs mere
2
Paxlovid Weaker Against Current COVID-19 Variants
Medscape Infectious Diseases, 23.09.2023
Tilføjet 23.09.2023
A real-world study found that Pfizer\'s COVID-19 antiviral Paxlovid is now less effective at preventing hospitalization or death in high-risk patients as compared with earlier studies. WebMD Health News
Læs mere
3
Communicable disease threats report, 17-23 September 2023, week 38
ECDC
ECDC Communicable Disease Threats Report, 22.09.2023
Tilføjet 22.09.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 September 2023 and includes updates on Nipah virus disease, severe floods, COVID-19, West Nile Virus, Poliomyelitis, and mass gathering monitoring for the Rugby World Cup 2023.
Læs mere
4
Creatine May Improve Key Long COVID Symptoms: Small Study
Medscape Infectious Diseases, 22.09.2023
Tilføjet 22.09.2023
This study evaluated the efficacy and safety of supplemental creatine for fatigue, tissue bioenergetics, and patient-reported outcomes in patients with post–COVID-19 fatigue syndrome. MDedge News
Læs mere
5
Communicable disease threats report, 17-23 September 2023, week 38
ECDC
ECDC COVID-19 updates, 22.09.2023
Tilføjet 22.09.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 September 2023 and includes updates on Nipah virus disease, severe floods, COVID-19, West Nile Virus, Poliomyelitis, and mass gathering monitoring for the Rugby World Cup 2023.
Læs mere
6
Surveillance of SARS-CoV-2 infection based on self-administered swabs, Denmark, May to July 2022: evaluation of a pilot study
Kamille Fogh, Tine Graakjær Larsen, Cyril Jean-Marie Martel, Frederik Trier Møller, Lasse Skafte Vestergaard, Ramona Trebbien, Anne-Marie Vangsted and Tyra Grove Krause
Eurosurveillance latest updates, 22.09.2023
Tilføjet 22.09.2023
BackgroundDuring the COVID-19 pandemic, the Danish National Institute for Infectious Disease, Statens Serum Institute (SSI) developed a home-based SARS-CoV-2 surveillance system. AimsWe wanted to determine whether a cohort of individuals performing self-administered swabs for PCR at home could support surveillance of SARS-CoV-2, including detection and assessment of new variants. We also aimed to evaluate the logistical setup. MethodsFrom May to July 2022, 10,000 blood donors were invited to participate, along with their household members. Participation required performing a self-swab for 4 consecutive weeks and answering symptom questionnaires via a web app. Swabs were sent by post to SSI for PCR analysis and whole genome sequencing. After study completion, participants were asked to complete a questionnaire concerning their experience. ResultsIn total, 2,186 individuals enrolled (47.4% blood donors), and 1,333 performed self-swabbing (53.0 blood donors), of whom 48 had at least one SARS-CoV-2-positive sample. Fourteen different Omicron subvariants, primarily BA.5 subvariants, were identified by whole genome sequencing (WGS). In total, 29 of the 63 SARS-CoV-2-positive samples were taken from individuals who were asymptomatic at the time of swabbing. Participants collected 2.9 swabs on average, with varying intervals between swabs. Transmission within households was observed in only three of 25 households. ConclusionParticipants successfully performed self-swabs and answered symptom questionnaires. Also, WGS analysis of samples was possible. The system can support surveillance of respiratory pathogens and also holds potential as a diagnostic tool, easing access to test for at-risk groups, while also reducing the burden on healthcare system resources.
Læs mere
7
Can variants, reinfection, symptoms and test types affect COVID-19 diagnostic performance? A large-scale retrospective study of AG-RDTs during circulation of Delta and Omicron variants, Czechia, December 2021 to February 2022
Tomáš Kliegr, Jiří Jarkovský, Helena Jiřincová, Jaroslav Kuchař, Tomáš Karel, David Chudán, Stanislav Vojíř, Michal Zavřel, Ondřej Šanca and Ruth Tachezy
Eurosurveillance latest updates, 22.09.2023
Tilføjet 22.09.2023
BackgroundThe sensitivity and specificity of selected antigen detection rapid diagnostic tests (AG-RDTs) for SARS-CoV-2 were determined in the unvaccinated population when the Delta variant was circulating. Viral loads, dynamics, symptoms and tissue tropism differ between Omicron and Delta. AimWe aimed to compare AG-RDT sensitivity and specificity in selected subgroups during Omicron vs Delta circulation. MethodsWe retrospectively paired AG-RDT results with PCRs registered in Czechia’s Information System for Infectious Diseases from 1 to 25 December 2021 (Delta, n = 20,121) and 20 January to 24 February 2022 (Omicron, n = 47,104). ResultsWhen confirmatory PCR was conducted on the same day as AG-RDT as a proxy for antigen testing close to peak viral load, the average sensitivity for Delta was 80.4% and for Omicron 81.4% (p
Læs mere
8
Wastewater Data Hint at Possible COVID Decline in Some Areas
Medscape Infectious Diseases, 22.09.2023
Tilføjet 22.09.2023
The summer-long surge of COVID-19 may be peaking in some parts of the US, according to wastewater monitoring. WebMD Health News
Læs mere
9
ECDC Director: Protect people’s health this autumn through vaccination and other preventive measures
ECDC
ECDC COVID-19 updates, 21.09.2023
Tilføjet 21.09.2023
Statement from ECDC Director Andrea Ammon on the current state of influenza, RSV and COVID-19 with the arrival of autumn and winter.
Læs mere
10
European Commission Approves First Tocilizumab Biosimilar
Medscape Infectious Diseases, 21.09.2023
Tilføjet 21.09.2023
The biosimilar, commercially called Tyenne, is indicated to treat several autoimmune diseases as well as cytokine release syndrome and COVID-19. Medscape Medical News
Læs mere
11
Paxlovid, Lagevrio Benefit COVID Outpatients in Omicron Era
Medscape Infectious Diseases, 20.09.2023
Tilføjet 20.09.2023
The American College of Physicians has issued an updated version of its living, rapid practice point guideline on the best treatment options for outpatients with confirmed COVID-19. MDedge News
Læs mere
12
Communicable disease threats report, 10-16 September 2023, week 37
ECDC
ECDC Communicable Disease Threats Report, 15.09.2023
Tilføjet 15.09.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 September 2023 and includes updates on COVID-19, diphtheria, West Nile virus, avian influenza, dengue, legionnaires\' disease, the Rugby World Cup 2023, cutaneous Anthrax, pertussis, botulism and severe floods.
Læs mere
13
Communicable disease threats report, 10-16 September 2023, week 37
ECDC
ECDC COVID-19 updates, 15.09.2023
Tilføjet 15.09.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 September 2023 and includes updates on COVID-19, diphtheria, West Nile virus, avian influenza, dengue, legionnaires\' disease, the Rugby World Cup 2023, cutaneous Anthrax, pertussis, botulism and severe floods.
Læs mere
14
PCPs Prep for 'Less Predictable' Respiratory Virus Season
Medscape Infectious Diseases, 15.09.2023
Tilføjet 15.09.2023
On the cusp of respiratory virus season, experts offer their guidance to primary care physicians about how to advise patients about vaccines for COVID-19, influenza, and RSV. Medscape Medical News
Læs mere
15
The re-emergence of influenza following the COVID-19 pandemic in Victoria, Australia, 2021 to 2022
Catherine GA Pendrey, Janet Strachan, Heidi Peck, Ammar Aziz, Jean Moselen, Rob Moss, Md Rezanur Rahaman, Ian G Barr, Kanta Subbarao and Sheena G Sullivan
Eurosurveillance latest updates, 15.09.2023
Tilføjet 15.09.2023
BackgroundCOVID-19 pandemic mitigation measures, including travel restrictions, limited global circulation of influenza viruses. In Australia, travel bans for non-residents and quarantine requirements for returned travellers were eased in November 2021, providing pathways for influenza viruses to be re-introduced. AimWe aimed to describe the epidemiological and virological characteristics of the re-emergence of influenza in Victoria, Australia to inform public health interventions. MethodsFrom 1 November 2021 to 30 April 2022, we conducted an epidemiological study analysing case notification data from the Victorian Department of Health to describe case demographics, interviewed the first 200 cases to establish probable routes of virus reintroduction and examined phylogenetic and antigenic data to understand virus diversity and susceptibility to current vaccines. ResultsOverall, 1,598 notifications and 1,064 positive specimens were analysed. The majority of cases (61.4%) occurred in the 15–34 years age group. Interviews revealed a higher incidence of international travel exposure during the first month of case detections, and high levels of transmission in university residential colleges were associated with return to campus. Influenza A(H3N2) was the predominant subtype, with a single lineage predominating despite multiple importations. ConclusionEnhanced testing for respiratory viruses during the COVID-19 pandemic provided a more complete picture of influenza virus transmission compared with previous seasons. Returned international travellers were important drivers of influenza reemergence, as were young adults, a group whose role has previously been under-recognised in the establishment of seasonal influenza epidemics. Targeting interventions, including vaccination, to these groups could reduce future influenza transmission.
Læs mere
16
SGLT2-inhibitors: No Benefit in Hospitalized COVID-19
Medscape Infectious Diseases, 14.09.2023
Tilføjet 14.09.2023
However, an important take-home message from this new meta-analysis is that these widely used medications appeared to be safe even in acutely ill hospitalized patients, the researchers say. Medscape Medical News
Læs mere
17
FDA Authorizes New COVID-19 Vaccine
Medscape Infectious Diseases, 12.09.2023
Tilføjet 12.09.2023
The FDA today authorized the newest COVID-19 vaccine, the first not to target the initial or \'ancestral\' strain of the virus. WebMD Health News
Læs mere
18
Communicable disease threats report, 3-9 September 2023, week 36
ECDC
ECDC Communicable Disease Threats Report, 8.09.2023
Tilføjet 8.09.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 September 2023 and includes updates on measles, MERS, COVID-19, mpox, iatrogenic botulism, echovirus, West Nile virus, dengue, Legionnaire\'s disease, swine flu, and mass gathering monitoring for the Rugby World Cup 2023.
Læs mere
19
A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022
Tommy Nyberg, Peter Bager, Ingrid Bech Svalgaard, Dritan Bejko, Nick Bundle, Josie Evans, Tyra Grove Krause, Jim McMenamin, Joël Mossong, Heather Mutch, Ajibola Omokanye, André Peralta-Santos, Pedro Pinto-Leite, Jostein Starrfelt, Simon Thelwall, Lamprini Veneti, Robert Whittaker, John Wood, Richard Pebody and Anne M Presanis
Eurosurveillance latest updates, 8.09.2023
Tilføjet 8.09.2023
Several SARS-CoV-2 variants that evolved during the COVID-19 pandemic have appeared to differ in severity, based on analyses of single-country datasets. With decreased testing and sequencing, international collaborative studies will become increasingly important for timely assessment of the severity of new variants. Therefore, a joint WHO Regional Office for Europe and ECDC working group was formed to produce and pilot a standardised study protocol to estimate relative case-severity of SARS-CoV-2 variants during periods when two variants were co-circulating. The study protocol and its associated statistical analysis code was applied by investigators in Denmark, England, Luxembourg, Norway, Portugal and Scotland to assess the severity of cases with the Omicron BA.1 virus variant relative to Delta. After pooling estimates using meta-analysis methods (random effects estimates), the risk of hospital admission (adjusted hazard ratio (aHR) = 0.41; 95% confidence interval (CI): 0.31−0.54), admission to intensive care unit (aHR = 0.12; 95% CI: 0.05−0.27) and death (aHR = 0.31; 95% CI: 0.28−0.35) was lower for Omicron BA.1 compared with Delta cases. The aHRs varied by age group and vaccination status. In conclusion, this study demonstrates the feasibility of conducting variant severity analyses in a multinational collaborative framework and adds evidence for the reduced severity of the Omicron BA.1 variant.
Læs mere
20
Field Epidemiology: Fit for the future
Susan Hahné, Charlotte Hammer, Alma Tostmann, Jane Whelan and Christopher Williams
Eurosurveillance latest updates, 8.09.2023
Tilføjet 8.09.2023
In recent years, field epidemiologists have embraced rapidly evolving digital tools, data sources and technologies, and collaborated with an ever-growing field of scientific specialisms. The COVID-19 pandemic put field epidemiology under unprecedented demand and scrutiny. As the COVID-19 emergency recedes, it is timely to reflect on the core values of our profession and the unique challenges and opportunities that lie ahead. In November 2022, alumni of the European Programme for Intervention Epidemiology Training (EPIET) and the European Public Health Microbiology (EUPHEM) training programme celebrated 25 years of EPIET, and the present and future of field epidemiology was discussed. The output was recorded and qualitatively analysed. This Perspective reflects the authors’ interpretation of the discussion. We should reaffirm our commitment to field epidemiology’s core strengths: competence and rigour in epidemiology, surveillance, outbreak investigation and applied research, leading to timely and actionable evidence for public health. Our future success will be defined by an ability to adapt, collaborate, harness innovation, communicate and, ultimately, by our tangible impact on protecting and improving health.
Læs mere
21
Field Epidemiology and Public Health Microbiology training: capturing the alumni perspectives of the training’s impact
Justine Schaeffer, Charlotte Christiane Hammer, Iro Evlampidou, Laura Bubba, Zsofia Igloi, Timothée Dub, Annika Wendland, Jane Whelan, Stine Nielsen, Amrish Baidjoe, Alma Tostmann and on behalf of the EPIET Alumni Network Boards 2017–2023
Eurosurveillance latest updates, 8.09.2023
Tilføjet 8.09.2023
We present the findings from the European Programme for Intervention Epidemiology Training (EPIET) Alumni Network (EAN) Member Survey conducted in October to December 2021. The EAN consists of field epidemiologists (EPIET) and public health microbiologists (European Public Health Microbiology Training Programme (EUPHEM)) who stay connected after their 2-year fellowship. This active alumni network provides opportunities for career development, mentorship, knowledge exchange and sharing of best practices for community members, affiliated professionals and public health organisations in Europe. Overall, 281 of 732 members participated in the survey. Of the 192 European fellowship alumni respondents, 173 (90%) indicated that skills and competencies acquired during their fellowship improved performance in their role compared with their abilities before the fellowship. Reported skills and competencies that could be further strengthened included data management/analysis, communication, mathematical modelling and leadership/team management. The EAN Member Survey provides valuable feedback to the EAN, as well as the fellowship programme offices at the European Centre for Disease Prevention and Control (ECDC) and affiliated field epidemiology programmes. The COVID-19 pandemic was a stark reminder of how essential cross-border collaborations are for continued European health security. Maintaining and increasing the professional, well-trained workforce remains crucial for optimal response to infectious diseases and protection of public health.
Læs mere
22
Sustained increase of paediatric invasive Streptococcus pyogenes infections dominated by M1UK and diverse emm12 isolates, Portugal, September 2022 to May 2023
Catarina Gouveia, Maria Paula Bajanca-Lavado, Rafael Mamede, Ana Araújo Carvalho, Fernanda Rodrigues, José Melo-Cristino, Mario Ramirez, Ana Friães, Portuguese Group for the Study of Streptococcal Infections and Portuguese Study Group of Pediatric Invasive Streptococcal Disease
Eurosurveillance latest updates, 8.09.2023
Tilføjet 8.09.2023
Since autumn 2022, observed numbers of paediatric invasive group A Streptococcus infections in Portugal (n = 89) were higher than in pre-COVID-19 seasons. Between September 2022 and May 2023, the dominant diagnoses were pneumonia (25/79), mostly with empyema (20/25), and sepsis (22/79). A number of cases required admission to intensive care (27/79) and surgery (35/79), and the case fatality rate was 5.1% (4/79). Genomic sequencing (n = 55) revealed multiple genetic lineages, dominated by the M1UK sublineage (26/55) and more diverse emm12 isolates (12/55).
Læs mere
23
First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
Morten Rasmussen, Frederik Trier Møller, Vithiagaran Gunalan, Sharmin Baig, Marc Bennedbæk, Lasse Engbo Christiansen, Arieh Sierra Cohen, Kirsten Ellegaard, Anders Fomsgaard, Kristina Træholt Franck, Nicolai Balle Larsen, Tine Graakjær Larsen, Ria Lassaunière, Charlotta Polacek, Amanda Gammelby Qvesel, Raphael Niklaus Sieber, Lasse Dam Rasmussen, Marc Stegger, Katja Spiess, Man-Hung Eric Tang, Lasse Skafte Vestergaard, Thomas Emil Andersen, Silje Vermedal Hoegh, Rune Micha Pedersen, Marianne Nielsine Skov, Kat Steinke, Thomas Vognbjerg Sydenham, Morten Hoppe, Lene Nielsen, Tyra Grove Krause, Henrik Ullum and Pikka Jokelainen
Eurosurveillance latest updates, 8.09.2023
Tilføjet 8.09.2023
We describe 10 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant BA.2.86 detected in Denmark, including molecular characteristics and results from wastewater surveillance that indicate that the variant is circulating in the country at a low level. This new variant with many spike gene mutations was classified as a variant under monitoring by the World Health Organization on 17 August 2023. Further global monitoring of COVID-19, BA.2.86 and other SARS-CoV-2 variants is highly warranted.
Læs mere
24
Epidemiological update: COVID-19 transmission in the EU/EEA, SARS-CoV-2 variants, and public health considerations for Autumn 2023
ECDC
ECDC Epidemiological Update, 8.09.2023
Tilføjet 8.09.2023
In recent weeks, signals of SARS-CoV-2 transmission have increased from previously very low levels in the EU/EEA.
Læs mere
25
Epidemiological update: COVID-19 transmission in the EU/EEA, SARS-CoV-2 variants, and public health considerations for Autumn 2023
ECDC
ECDC COVID-19 updates, 7.09.2023
Tilføjet 7.09.2023
In recent weeks, signals of SARS-CoV-2 transmission have increased from previously very low levels in the EU/EEA.
Læs mere
26
ECDC publishes epidemiological update on increased COVID-19 transmission, SARS-CoV-2 variants, and public health considerations for autumn 2023
ECDC
ECDC COVID-19 updates, 7.09.2023
Tilføjet 7.09.2023
Today ECDC is providing an update on the current status of COVID-19 transmission in the European Union and European Economic Area (EU/EEA), the emergence of new SARS-CoV-2 variants, and public health considerations for Autumn 2023.
Læs mere
27
Communicable disease threats report, 27 August - 2 September 2023, week 35
ECDC
ECDC Communicable Disease Threats Report, 1.09.2023
Tilføjet 1.09.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 August - 2 September and includes updates on Legionnaires’ disease, dengue cases, avian influenza, West Nile virus, COVID-19 and cholera.
Læs mere
28
COVID-19 Hospitalizations and Deaths on the Rise
Medscape Infectious Diseases, 1.09.2023
Tilføjet 1.09.2023
Last week COVID-19 hospitalizations rose by 19% and deaths rose by 21%, according to figures from the CDC. WebMD Health News
Læs mere
29
Communicable disease threats report, 27 August - 2 September 2023, week 35
ECDC
ECDC COVID-19 updates, 1.09.2023
Tilføjet 1.09.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 August - 2 September and includes updates on Legionnaires’ disease, dengue cases, avian influenza, West Nile virus, COVID-19 and cholera.
Læs mere
30
Reversed urban–rural gradient in COVID-19 seroprevalence and related factors in a nationally representative survey, Poland, 29 March to 14 May 2021
Michał Czerwiński1, Małgorzata Stępień1, Grzegorz Juszczyk2, Małgorzata Sadkowska-Todys1, Adam Zieliński1, Jakub Rutkowski1 and Magdalena Rosińska1
Eurosurveillance latest updates, 1.09.2023
Tilføjet 1.09.2023
BackgroundWe anticipated that people in rural areas and small towns with lower population density, lower connectivity and jobs less dependent on social interaction will be less exposed to COVID-19. Still, other variables correlated with socioeconomic inequalities may have a greater impact on transmission. AimWe investigated how COVID-19 affected rural and urban communities in Poland, focussing on the most exposed groups and disparities in SARS-CoV-2 transmission. MethodsA random digit dial sample of Polish adults stratified by region and age was drawn from 29 March to 14 May 2021. Serum samples were tested for anti-S1 and anti-N IgG antibodies, and positive results in both assays were considered indicative of past infection. Seroprevalence estimates were weighted to account for non-response. Adjusted odds ratios (AORs) were calculated using multivariable logistic regression. ResultsThere was serological evidence of infection in 32.2% (95% CI: 30.2–34.4) of adults in rural areas/small towns (
Læs mere
31
Ongoing measles outbreaks in Romania, March 2023 to August 2023
Mihaela Lazar, Cătălina Pascu, Maria Roșca and Aurora Stănescu
Eurosurveillance latest updates, 1.09.2023
Tilføjet 1.09.2023
Measles cases have recently been increasing in Romania, with 460 confirmed cases by August 2023. From March 2023, measles cases increased, and outbreaks were recorded in Cluj, Bistrita Nasaud, Sibiu and Mures counties. New D8 virus variants were identified, different from the variants detected in Romania before the COVID-19 pandemic. We here provide epidemiological and molecular data on the current increase in measles cases in the context of the measles elimination process in the World Health Organization European Region.
Læs mere
32
COVID Metrics Tick Up, but Americans Aren't Worried: Poll
Medscape Infectious Diseases, 31.08.2023
Tilføjet 31.08.2023
Just 7% of US adults are \'very worried\' about getting COVID-19, according to a new poll. WebMD Health News
Læs mere
33
People With Liver Disease Can Now Take Remdesivir for COVID
Medscape Infectious Diseases, 29.08.2023
Tilføjet 29.08.2023
The move is important because, previously, some people with liver disease had limited treatment options for severe cases of COVID-19. WebMD Health News
Læs mere
34
Use of Mental Health Services Soared During Pandemic
Medscape Infectious Diseases, 28.08.2023
Tilføjet 28.08.2023
In addition, a majority of large employers report in a national survey that they are seeing increased mental health issues among workers due to COVID-19. Medscape Medical News
Læs mere
35
Communicable disease threats report, 20-26 August 2023, week 34
ECDC
ECDC Communicable Disease Threats Report, 26.08.2023
Tilføjet 26.08.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 20-26 August and includes updates on avian influenza, botulism, autochthonous dengue, Legionnaires\' disease, COVID-19, West Nile virus, Chikungunya and dengue.
Læs mere
36
Some People With Long COVID Tested Negative for COVD-19
Medscape Infectious Diseases, 26.08.2023
Tilføjet 26.08.2023
Some cases of long COVID-19 might be missed because the patient\'s initial infection wasn\'t detected. WebMD Health News
Læs mere
37
Communicable disease threats report, 20-26 August 2023, week 34
ECDC
ECDC COVID-19 updates, 25.08.2023
Tilføjet 25.08.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 20-26 August and includes updates on avian influenza, botulism, autochthonous dengue, Legionnaires\' disease, COVID-19, West Nile virus, Chikungunya and dengue.
Læs mere
38
Forskere skal undersøge indeklima på skolerne
Statens Serum Institut, 25.08.2023
Tilføjet 25.08.2023
Statens Serum Institut har modtaget en bevilling på fem millioner kroner fra Realdania til et pilotprojekt, der skal undersøge om forbedret luftkvalitet i landets skoler kan mindske risikoen for luftvejsinfektioner såsom covid-19.
Læs mere
39
New COVID Strain May Evade Vaccines
Medscape Infectious Diseases, 25.08.2023
Tilføjet 25.08.2023
A new strain of COVID-19 that was only identified a week ago in the US has prompted the CDC to take the rare step of issuing a formal message that it could evade vaccines or the protection of natural immunity. WebMD Health News
Læs mere
40
Back in Business: Primary Care and COVID-19 Prevention
Medscape Infectious Diseases, 25.08.2023
Tilføjet 25.08.2023
Primary care clinicians were sidelined in vaccine distribution during the height of the COVID-19 pandemic. But now these providers are looking toward resuming their role as a major provider of the shots. Medscape Medical News
Læs mere
41
Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA - Third update
ECDC
ECDC COVID-19 updates, 23.08.2023
Tilføjet 23.08.2023
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
Læs mere
42
COVID Cases Continue to Rise as Nation Awaits Updated Vaccine
Medscape Infectious Diseases, 23.08.2023
Tilføjet 23.08.2023
COVID-19 metrics keep ticking up, as the calendar counts down toward the end of September, when an updated vaccine is expected to be made available. WebMD Health News
Læs mere
43
CDC Tracking New COVID Strain
Medscape Infectious Diseases, 21.08.2023
Tilføjet 21.08.2023
"As we learn more about BA.2.86, CDC\'s advice on protecting yourself from COVID-19 remains the same." WebMD Health News
Læs mere
44
Communicable disease threats report, 13-19 August 2023, week 33
ECDC
ECDC COVID-19 updates, 19.08.2023
Tilføjet 19.08.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 August and includes updates on avian influenza A(H5N6), avian influenza A(H9N2), West Nile virus, COVID-19, poliomyelitis, and Crimean-Congo haemorrhagic fever.
Læs mere
45
Communicable disease threats report, 13-19 August 2023, week 33
ECDC
ECDC Communicable Disease Threats Report, 18.08.2023
Tilføjet 18.08.2023
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 13-19 August and includes updates on avian influenza A(H5N6), avian influenza A(H9N2), West Nile virus, COVID-19, poliomyelitis, and Crimean-Congo haemorrhagic fever.
Læs mere
46
A comparison of two registry-based systems for the surveillance of persons hospitalised with COVID-19 in Norway, February 2020 to May 2022
Robert Whittaker, Salla Toikkanen, Katharine Dean, Trude Marie Lyngstad, Eirik Alnes Buanes, Hilde Kløvstad, Trine Hessevik Paulsen and Elina Seppälä
Eurosurveillance latest updates, 18.08.2023
Tilføjet 18.08.2023
BackgroundThe surveillance of persons hospitalised with COVID-19 has been essential to ensure timely and appropriate public health response. Ideally, surveillance systems should distinguish persons hospitalised with COVID-19 from those hospitalised due to COVID-19. AimWe compared data in two national electronic health registries in Norway to critically appraise and inform the further development of the surveillance of persons hospitalised with COVID-19. MethodWe included hospitalised COVID-19 patients registered in the Norwegian Patient Registry (NPR) or the Norwegian Pandemic Registry (NoPaR) with admission dates between 17 February 2020 and 1 May 2022. We linked patients, identified overlapping hospitalisation periods and described the overlap between the registries. We described the prevalence of International Classification of Diseases (ICD-10) diagnosis codes and their combinations by main cause of admission (clinically assessed as COVID-19 or other), age and time. ResultsIn the study period, 19,486 admissions with laboratory-confirmed COVID-19 were registered in NoPaR and 21,035 with the corresponding ICD-10 code U07.1 in NPR. Up to late 2021, there was a 90–100% overlap between the registries, which thereafter decreased to
Læs mere
47
ECDC classifies XBB.1.5-like lineages with the amino acid change F456L as variants of interest following an increase in SARS-CoV-2 transmission in EU/EEA countries and abroad
ECDC
ECDC Epidemiological Update, 18.08.2023
Tilføjet 18.08.2023
In 2023, after several months of very low rates of infection, coronavirus disease 2019 (COVID-19) transmission has started to increase in some EU/EEA countries.
Læs mere
48
COVID Hospitalizations Climb for Fourth Straight Week
Medscape Infectious Diseases, 18.08.2023
Tilføjet 18.08.2023
The CDC now relies on hospitalization data to gauge the current impact of COVID-19. WebMD Health News
Læs mere
49
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023
Morbidity and Mortality Weekly Report (MMWR), 18.08.2023
Tilføjet 18.08.2023
This report describes the effectiveness of monovalent and bivalent mRNA COVID-19 vaccines among children 6 months-5 yearsThis report describes the effectiveness of monovalent and bivalent mRNA COVID-19 vaccines among children 6 months-5 years
Læs mere
50
ECDC classifies XBB.1.5-like lineages with the amino acid change F456L as variants of interest following an increase in SARS-CoV-2 transmission in EU/EEA countries and abroad
ECDC
ECDC COVID-19 updates, 18.08.2023
Tilføjet 18.08.2023
In 2023, after several months of very low rates of infection, coronavirus disease 2019 (COVID-19) transmission has started to increase in some EU/EEA countries.
Læs mere